MassMutual Private Wealth & Trust’s Dianthus Therapeutics DNTH Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390	Buy	+4	New	+$349	﹤0.01%	2306

Other funds holding DNTH

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

PFA

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

MassMutual Private Wealth & Trust's DNTH Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 4 shares worth $390. The stake represents ﹤0.01% of the portfolio and ranks #2306 among its holdings.

37 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

MassMutual Private Wealth & Trust held 4 shares of Dianthus Therapeutics worth $390 as of Q2 2026.
Dianthus Therapeutics was a new MassMutual Private Wealth & Trust position in Q2 2026.
Dianthus Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2306 holding.
37 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.